Winning the attention of Big Pharma requires more than strong technical capabilities. With hundreds of CDMOs competing for new projects, smaller and mid-sized organisations must clearly communicate their value proposition, demonstrate credibility, and position themselves as trusted long-term partners.
In this opinion spotlight, Mohammed Fayez, Head of Third-Party Manufacturing at Boehringer Ingelheim, shares the sponsor perspective on how CDMOs can best promote themselves to large pharmaceutical companies. From first impressions to lasting partnerships, gain practical insights into what helps a CDMO get noticed and move from consideration to contract.
Key takeaways include:
• How to effectively position your CDMO to appeal to Big Pharma decision-makers.
• The capabilities and differentiators that should be front and centre in your messaging.
• Common mistakes CDMOs make when promoting their services and how to avoid them.